SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-21-000115
Filing Date
2021-11-02
Accepted
2021-11-02 16:05:06
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20210930.htm   iXBRL 10-Q 1125092
2 EX-31.1 exhibit31-1q32021.htm EX-31.1 9174
3 EX-31.2 exhibit31-2q32021.htm EX-31.2 9176
4 EX-32.1 exhibit32-1q32021.htm EX-32.1 4104
5 EX-32.2 exhibit32-2q32021.htm EX-32.2 3939
  Complete submission text file 0001125345-21-000115.txt   4891971

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20210930.xsd EX-101.SCH 29640
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20210930_cal.xml EX-101.CAL 42138
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20210930_def.xml EX-101.DEF 173959
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20210930_lab.xml EX-101.LAB 417293
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20210930_pre.xml EX-101.PRE 292483
11 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20210930_htm.xml XML 771017
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 211371183
SIC: 2834 Pharmaceutical Preparations